Brickell Biotech Overview

  • Founded
  • 2009
Founded
  • Status
  • Public
  • Employees
  • 13
Employees
  • Stock Symbol
  • BBI
Stock Symbol
  • Investments
  • 1
  • Share Price
  • $0.72
  • (As of Tuesday Closing)

Brickell Biotech General Information

Description

Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics for the treatment of skin diseases. Its pipeline consists of therapeutics for Hyperhidrosis, Cutaneous T-cell lymphoma, Psoriasis, and Other prevalent severe skin diseases. The company's pipeline products include Sofpironium Bromide, BBI-3000, and BBI-6000 among others.

Contact Information

Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Drug Delivery
Other Industries
Biotechnology
Pharmaceuticals
Stock Exchange
NAS
Primary Office
  • 5777 Central Avenue
  • Suite 102
  • Boulder, CO 80301
  • United States
+1 (720) 000-0000

Brickell Biotech Timeline

2018201920202021
Financing RoundFinancing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Brickell Biotech Stock Performance

(As of Tuesday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$0.72 $0.71 $0.47 - $1.70 $61M 85.9M 1.18M -$0.61

Brickell Biotech Financials Summary

In Thousands,
USD
TTM 30-Jun-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019 FY 2018 31-Dec-2018
EV 29,618 22,119 (13,813) (24,625)
Revenue 337 1,822 7,917 1,622
EBITDA (31,769) (20,903) (21,753) (16,103)
Net Income (31,845) (20,913) (23,877) (16,254)
Total Assets 29,073 33,634 18,144 52,344
Total Debt 86 511 151
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Brickell Biotech Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Brickell Biotech‘s full profile, request access.

Request a free trial

Brickell Biotech Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Brickell Biotech Inc is a United States-based clinical-stage pharmaceutical company focused on developing therapeutics f
Drug Delivery
Boulder, CO
13 As of 2020
000.00
00000000 000.00

00000000

giat nulla pariatur. Excepteur sint occaecat cupidatat non proident, sunt in culpa qui officia deser
0000000000000
Long Beach, CA
00 As of 0000
00000
0000000 0000 00000

0000000

tetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad
000000000000000
Menlo Park, CA
000 As of 0000
00000
0.000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Brickell Biotech Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Dermavant Sciences Private Equity-Backed Long Beach, CA 00 00000 0000000 0000 00000
0000000 Formerly VC-backed Menlo Park, CA 000 00000 000000&0 00000
0000000 0000000000 Formerly VC-backed Dublin, Ireland 00 00000 000000000 00000
0000000 Formerly VC-backed San Diego, CA 0 000.00 00000000 000.00
000000 00000000000 Formerly PE-Backed Rehovot, Israel 00 000.00 000000&0 000.00
You’re viewing 5 of 20 competitors. Get the full list »

Brickell Biotech Executive Team (19)

Name Title Board Seat Contact Info
Robert Brown Chief Executive Officer & Board Member
Albert Marchio II Chief Financial Officer, Finance
Andrew Sklawer Founder & Chief Operating Officer, Operations
Jose Breton Chief Accounting Officer, Accounting & Controller, Finance
David McAvoy JD General Counsel, Legal & Chief Compliance Officer, Legal
You’re viewing 5 of 19 executive team members. Get the full list »

Brickell Biotech Board Members (12)

Name Representing Role Since
0000000 0000000 00 Self Chairman of the Advisory Board 000 0000
00000000 0000 Palisade Capital Management Board Member 000 0000
0000 00000 Self Board Member 000 0000
000000 00000000000 Self Board Member 000 0000
00000000 00000 Brickell Biotech Chairman & Founder 000 0000
You’re viewing 5 of 12 board members. Get the full list »

Brickell Biotech Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Brickell Biotech Acquisitions (1)

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
00000 03-Sep-2019 000000000000000000 Biotechnology 000000 00000
To view Brickell Biotech’s complete acquisitions history, request access »